Portfolio Construction Governance Adviser

The mandate

The Adviser will help the Investment Committee examine whether quantitative portfolio construction remains consistent with approved objectives when forecasts, constraints, costs and concentration interact. The standing question is whether optimisation output is a robust decision aid or a fragile solution to assumptions. There is no line authority, portfolio mandate or trade-approval right.

Three weekly adviser days will cover a fortnightly methodology clinic, monthly robustness review and two planned committee sessions. Management supplies approved objectives, constraints, forecast evidence, cost assumptions and outcome analysis. The Adviser will challenge the decision logic but will not generate production portfolios, execute transactions or act as a fiduciary manager.

Advice will examine objective-function choice, covariance and expected-return uncertainty, turnover, transaction cost, liquidity, concentration, exposure bounds, regime sensitivity and the treatment of estimation error. The Adviser should test whether minor input perturbations cause disproportionate allocation change and whether qualitative overrides are explicit rather than hidden inside constraints.

Where alternative construction methods disagree, the Adviser will trace the divergence to inputs, objective, constraint or solution instability. A disagreement is useful evidence; it must not be averaged into a compromise portfolio that no method actually supports.

The committee and accountable executives retain every decision. Written observations will identify decisive assumptions, alternatives, confidence limits and conditions requiring reconsideration. Advice is not independent model validation or an investment recommendation to any external party.

At six months, expected legacy includes a robustness protocol, clearer constraint register, improved override documentation and a committee-ready uncertainty presentation. Conflicts involving investments, managers, data providers, model vendors or recent portfolio work must be declared before holdings or strategies are disclosed.

What you will own

• Review whether objectives, horizons and constraints accurately represent approved decision intent.
• Challenge expected-return, covariance and cost inputs for stability, evidence and sensitivity to estimation choices.
• Test concentration, liquidity, turnover and exposure outcomes across plausible regimes and input perturbations.
• Identify constraints that encode unapproved judgment or conceal qualitative overrides from committee review.
• Compare optimisation with transparent benchmarks and alternative construction methods to expose false precision.
• Frame committee questions around uncertainty, trade-offs and downside behaviour rather than a single efficient solution.
• Recommend deeper validation where advisory robustness testing reveals unresolved model risk.
• Decline portfolio implementation, trading, fiduciary management and production-model ownership.

Candidate qualifications

• Demonstrate senior portfolio-construction expertise across optimisation, constraints and realised outcome analysis.
• Describe an optimal allocation that proved unstable under small, plausible input changes.
• Show how you exposed an implicit view hidden within a technical constraint or override.
• Evidence evaluation of turnover, liquidity and transaction cost without treating estimates as fixed facts.
• Explain how a simple benchmark revealed weakness in a sophisticated construction method.
• Provide an example of influencing committee action without an investment mandate.
• Identify personal or professional investment conflicts relevant to this work.

Working terms and boundaries

• The six-month retainer covers three days weekly, fortnightly clinics and two scheduled committee sessions monthly.
• There is no line authority, fiduciary mandate, model approval, trade authority or production responsibility.
• Management owns assumptions, allocations and implementation; the Adviser supplies independent challenge only.
• Additional event-driven attendance requires reprioritisation or a signed commercial amendment.
• Conflict clearance occurs before portfolios, managers, providers or holdings are revealed.

Application

Applications for this mandate are received in one way only: through the India Board Terminal's application process. It is automated end to end. Your Executive Passport travels to the mandate holder in its confidential form, your answers to the three questions below are read before anything else in your file, and every stage that follows is recorded on your applications page.

There is no address to write to and no intermediary to call. The mandate holder reads what the Terminal delivers and nothing else, which is what keeps the process the same for every applicant and keeps your name out of it until you release it. Applications close on 7 October 2026. Mandate reference QNT-ADV-2026-AMS-11.